Nearly half of patients who stop taking opioids for six months resume use later

A study by a team of Magellan researchers, demonstrating the pervasiveness of opioid addiction, was presented at the American Psychiatric Association (APA) Annual Meeting, and was also the subject of…

Read More

Magellan’s Collaboration with Click Therapeutics Expanded to Develop FDA-Cleared Therapeutic Apps

Over the past decade, technology has become enmeshed in our lives. From the ubiquitous smartphones we all carry, to connected houses, cars, cameras and more — it seems like just…

Read More
Magellan Health launches new thought leadership website

Emerging Therapies for Parkinson’s Disease

Did you know that Parkinson’s disease psychosis (PDP) is diagnosed in about half of all Parkinson’s diseases patients and presents practitioners with significant disease management challenges? The Journal of Managed…

Read More
Cobalt, Magellan's CCBT program, puts Cognitive Behavioral Therapy into your hands wherever you are.

Building Apps to Promote Healthy, Vibrant Lives: Magellan’s Digital Innovations

There are many healthcare-oriented apps in the marketplace, but there are few out there that offer cognitive behavioral therapy (CBT) and that have also been built on a multi-decade foundation…

Read More